6 Results for "

GSK-3α/β-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "GSK-3α/β-IN-1" in MCE Product Catalog:

Cat. No.: HY-172586
CAS No.: 1574354-24-7
Target:  

GSK-3 PKA

Research Areas:  

Neurological Disease Cancer

GSK-3α/β-IN-1 is GSK-3α/β inhibitor with IC50 s of 0.265 μM and 0.255 μM for GSK-3α and GSK-3β, respectively. GSK-3α/β-IN-1 also inhibits PKA with an IC50 of 0.188 μM. GSK-3α/β-IN-1 potently inhibits cell viability of three Glioblastoma (GBM) cell lines (IC50 : 3-6 μM, 72 h) with no toxicity to human astrocytes and good metabolic stability. GSK-3α/β-IN-1 has potential CNS activity in all-human blood-brain barrier (BBB) model of GBM [1].
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10580
CAS No.: 667463-62-9
Purity:  99.31%
Synonyms: 6-BromoINdirubIN-3'-oxime; BIO; MLS 2052
Target:  

GSK-3 CDK Apoptosis

Research Areas:  

Cancer

GSK 3 Inhibitor IX (6-Bromoindirubin-3'-oxime; BIO) is a potent, selective, reversible and ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex with IC50s of 5 nM/320 nM/80 nM for (GSK-3α/β)/CDK1/CDK5, respectively.
loading...
    loading...
Cat. No.: HY-111379
CAS No.: 1425945-63-6
Purity:  97.38%
Target:  

DYRK CDK GSK-3

EHT 5372 is a highly potent and selective inhibitor of DYRK's family kinases with IC50s of 0.22, 0.28, 10.8, 93.2, 22.8, 88.8, 59.0, 7.44, and 221 nM for DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, and GSK-3β, respectively .
loading...
    loading...
Cat. No.: HY-155805
Purity:  99.85%
Target:  

CDK

Research Areas:  

Cancer

CAF-382 (compound B1) is an analog of SNS-032 and a CDKL5 and pan-CDK inhibitor with a weak GSK3α/β affinity (>1.8 μM) and inhibitory activity. CAF-382 inhibits CDKL5 and blocks the phosphorylation of the CDKL5 E2 domain [1].
loading...
    loading...
Cat. No.: HY-162722
CAS No.: 1772823-37-6
Target:  

GSK-3

Research Areas:  

Others

GSK-3 inhibitor 6 (2) is a CNS penetrated GSK-3 inhibitor, with IC50 values of 29 nM and 24 nM for GSK-3α and GSK-3β, respectively .
loading...
    loading...
Cat. No.: HY-10580R
CAS No.: 667463-62-9
Synonyms: 6-BromoINdirubIN-3'-oxime (Standard); BIO (Standard); MLS 2052 (Standard)
Research Areas:  

Cancer

GSK 3 Inhibitor IX (Standard) is the analytical standard of GSK 3 Inhibitor IX (HY-10580). This product is intended for research and analytical applications. GSK 3 Inhibitor IX (6-Bromoindirubin-3'-oxime; BIO) is a potent, selective, reversible and ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex with IC50s of 5 nM/320 nM/80 nM for (GSK-3α/β)/CDK1/CDK5, respectively.
loading...
    loading...